Navigation Links
FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures
Date:1/29/2010

RESEARCH TRIANGLE PARK, N.C., Jan. 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary generalized tonic-clonic seizures.  This is an expanded label, as Lamictal XR is approved for partial onset seizures (with or without secondary generalization) for patients in this age group.

Primary generalized tonic-clonic seizures, known formerly as "grand mal" seizures, are considered the most common form of generalized (affecting both sides of the brain) seizure, occurring in approximately 20 percent of patients with epilepsy.  Patients experiencing a generalized tonic-clonic seizure usually lose consciousness and collapse.  This is followed by muscle stiffening (the tonic phase) and then jerking involving both sides of the body (the clonic phase).  

In a clinical study, the addition of Lamictal XR reduced seizure frequency more than placebo in patients with uncontrolled primary generalized tonic-clonic seizures, when used in adjunctive therapy for patients 13 years of age and older.  The patients in the study were not adequately controlled despite being on one or two anti-epileptic drugs.  

"We were encouraged that the study showed such a significant reduction in the number of primary generalized tonic-clonic seizures in patients who received Lamictal XR in addition to their current regimen.  Over the 19 week treatment period, the median percent reduction in weekly seizure frequency was 75 percent in patients treated with Lamictal XR c
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Chinese State Food and Drug Administration Approves Company Facility for Producing Solid Dosage Perindopril
2. FDA Approves Ampyra to Improve Walking in Adults with Multiple Sclerosis
3. FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older
4. FDA Approves Lillys ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
5. FDA Approves Lillys Zyprexa for Two Adolescent Indications
6. US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
7. FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus
8. FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
9. FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
10. FDA Approves Agriflu Seasonal Influenza Vaccine
11. FDA Approves Lysteda to Treat Heavy Menstrual Bleeding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... and MENLO PARK, Calif. ... Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... commercialization of new cancer therapies, today announced that ... Comparison of the Mechanisms and Cytotoxic Activity of ... Harboring Wild-type and Mutant p53," at the ...
(Date:9/2/2015)... , Sept. 2, 2015 ... a broad spectrum of physicians who prescribe ... Association of Clinical Endocrinologists, American College of ... Rheumatology Organizations, and North American Society for ... a letter to Centers for Medicare and ...
(Date:9/2/2015)... Sept. 2, 2015  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... immunotherapies, announced today that members of its leadership team ... September, including: , First World Congress ... and Food & Environmental Technologies; Portoroz, Slovenia ... Global Investment Conference; New York, NY ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 3DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 4Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 2Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 3Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 4Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 5Physician Groups Urge CMS: Follow FDA Lead on Unique Names for Biological Medicines 6OncoSec to Present at Scientific and Investment Conferences in September 2OncoSec to Present at Scientific and Investment Conferences in September 3OncoSec to Present at Scientific and Investment Conferences in September 4OncoSec to Present at Scientific and Investment Conferences in September 5
... Mich., May 20, 2011 Ann Arbor SPARK recently celebrated ... investor pitches and a reception.  At the Ann Arbor SPARK ... "Best of Boot Camp" winner, based on the quality of ... received an engagement though the Ann Arbor SPARK Business Accelerator. ...
... May 20, 2011 HealthPartners Medical Group ... Group today announce a unique collaboration to ... in health care quality and patient service, while ... leading national healthcare management consulting firm, and HPMG, ...
Cached Medicine Technology:Brio Device Awarded Best of Ann Arbor SPARK's Boot Camp 2HealthPartners and The Chartis Group Collaborate to Improve Health Care Quality, Service, and Cost 2HealthPartners and The Chartis Group Collaborate to Improve Health Care Quality, Service, and Cost 3HealthPartners and The Chartis Group Collaborate to Improve Health Care Quality, Service, and Cost 4
(Date:9/2/2015)... ... ... A recent survey by Consumer Reports ( http://bit.ly/1h67tL8 ) sheds light on the ... It was reported that 33% are paying an average of $39 more out-of-pocket for ... compared to last year. Among the drugs that saw the highest increases were those ...
(Date:9/2/2015)... ... 02, 2015 , ... EDAC Systems, Inc., a leading value-added ... services to both government and commercial clients, today announced the release of a ... Datacap document capture platform. EDAC PurePAGE processes and enhances the images whether ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... PHYTOMER, the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich ... new cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for ...
(Date:9/2/2015)... ... 02, 2015 , ... Dr. Robert G. Schwartz , the principal of ... “Systema”: a Russian martial art system that is also a philosophy of life that ... which dates back to the 10th century, is a Russian Martial Art that has ...
(Date:9/1/2015)... ... September 01, 2015 , ... An August ... thousands of plastic surgeries conducted each year on teenagers, quoting a New York ... numbers. Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly ...
Breaking Medicine News(10 mins):Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 2Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2
... recent study at the University of North Carolina in Chapel ... the National Cancer Institute suggests that two genes - C282Y ... hemochromatosis may also lead to an increased risk of developing ... 1,300 subjects were studied, out// of which, more than 400 ...
... A new study by researchers in Charleston has ... depressive disorder in individuals with diabetes. For the ... Health Interview Survey, which was used to evaluate ... researchers found that depressed individuals with diabetes, were ...
... the Johns Hopkins University School of Medicine in Baltimore cautioned ... screening for lung cancer. They claimed that the harm of ... that turn out to be benign,// and the costs of ... annual full-body CT screening. ,Following this, the National Cancer ...
... University in Boston has revealed that children as young as ... They also use emotional information picked up from adults around ... psychology at Tufts University, and her team tested //babies, showing ... red spiral letter holder, a blue bumpy ball, and a ...
... found that continuous combined hormone therapy(estrogen combined with 25 ... associated with an increased breast cancer risk among current ... for five or more years. The study however did ... hormone therapy and breast cancer risk. This indicated that ...
... by removing a disc or placing a bone graft in ... disc which is being studied as a replacement is in ... was recently completed compared the prosthesis to traditional fusion. While ... one having a fusion operation for every two that received ...
Cached Medicine News:Health News:Artificial discs available as replacements for damaged discs 2
... The VersaPulse PowerSuite holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... Nd:YAG technology has allowed for perfecting mini-invasive ... of various pathologies with a considerable social ... for reducing the post-operatory times and represents ... costs in all hospital structures.,DEKAs family of ...
... have to choose. The Apogee Elite ... 755nm Alexandrite laser and a high ... in one convenient unit. The ... for hair removal, pigmented lesions, facial ...
Single use trocar with non-conductive sleeves for gaining and maintaining thoracic access., ,THORACOPORT™ devices are trocars used to gain access to the thoracic cavity for use in video assis...
Medicine Products: